Laura Kohtamäki

Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients

Henna H.E. Kasanen, Micaela Hernberg, Siru Mäkelä et al. · Cancer Immunology Immunotherapy · 2020 · 21 citations · Full text

Medicine, Immunology, Oncology +17

Limited-duration anti-PD-1 therapy for patients with metastatic melanoma

Siru Mäkelä, Laura Kohtamäki, Marjut Laukka et al. · Acta Oncologica · 2020 · 10 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy

Hannes Vihinen, Artturi Jokinen, Teemu D. Laajala et al. · Clinical Lung Cancer · 2023 · 10 citations · Full text

Medicine, Immunology, Oncology +16